{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["127(10)"],"submitter":["Aasbo G"],"pubmed_abstract":["<h4>Background</h4>Cervical cancer screening participation is suboptimal in most settings. We assessed whether human papillomavirus (HPV) self-sampling may increase screening participation among long-term non-attenders in Norway.<h4>Methods</h4>A pragmatic randomised controlled trial with participation as the primary outcome was initiated in the national cervical screening programme in March 2019. A random sample of 6000 women aged 35-69 years who had not attended screening for at least 10 years were randomised 1:1:1 to receive either (i) a reminder to attend regular screening (control), (ii) an offer to order a self-sampling kit (opt-in) for HPV testing or (iii) a self-sampling kit unsolicited (send-to-all) for HPV testing.<h4>Results</h4>Total participation was 4.8%, 17.0% and 27.7% amon"],"journal":["British journal of cancer"],"pagination":["1816-1826"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9643532"],"repository":["biostudies-literature"],"pubmed_title":["HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial."],"pmcid":["PMC9643532"],"pubmed_authors":["Iversen GA","Presthus GK","Trope A","Castle PE","Christiansen MH","Undem K","Christiansen IK","Baasland I","Hansen BT","Nygard M","Aasbo G","Munk AC","Bjorge T"],"additional_accession":[]},"is_claimable":false,"name":"HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial.","description":"<h4>Background</h4>Cervical cancer screening participation is suboptimal in most settings. We assessed whether human papillomavirus (HPV) self-sampling may increase screening participation among long-term non-attenders in Norway.<h4>Methods</h4>A pragmatic randomised controlled trial with participation as the primary outcome was initiated in the national cervical screening programme in March 2019. A random sample of 6000 women aged 35-69 years who had not attended screening for at least 10 years were randomised 1:1:1 to receive either (i) a reminder to attend regular screening (control), (ii) an offer to order a self-sampling kit (opt-in) for HPV testing or (iii) a self-sampling kit unsolicited (send-to-all) for HPV testing.<h4>Results</h4>Total participation was 4.8%, 17.0% and 27.7% amon","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Nov","modification":"2026-05-28T01:07:46.154Z","creation":"2025-04-19T22:47:01.612Z"},"accession":"S-EPMC9643532","cross_references":{"pubmed":["35995936"],"doi":["10.1038/s41416-022-01954-9"]}}